167 related articles for article (PubMed ID: 21146893)
21. Lipid raft-dependent death receptor 5 (DR5) expression and activation are critical for ursodeoxycholic acid-induced apoptosis in gastric cancer cells.
Lim SC; Duong HQ; Choi JE; Lee TB; Kang JH; Oh SH; Han SI
Carcinogenesis; 2011 May; 32(5):723-31. PubMed ID: 21362627
[TBL] [Abstract][Full Text] [Related]
22. Plasma membrane phospholipase A2 controls hepatocellular fatty acid uptake and is responsive to pharmacological modulation: implications for nonalcoholic steatohepatitis.
Stremmel W; Staffer S; Wannhoff A; Pathil A; Chamulitrat W
FASEB J; 2014 Jul; 28(7):3159-70. PubMed ID: 24719358
[TBL] [Abstract][Full Text] [Related]
23. [CD38 protein reduces LPS/D-galactosamine-induced acute damage of liver tissues via down-regulating inflammatory cytokine expressions].
Wu Y; Liang L; Shi G
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1009-12. PubMed ID: 25270198
[TBL] [Abstract][Full Text] [Related]
24. Protective effect of baicalin against lipopolysaccharide/D-galactosamine-induced liver injury in mice by up-regulation of heme oxygenase-1.
Wan JY; Gong X; Zhang L; Li HZ; Zhou YF; Zhou QX
Eur J Pharmacol; 2008 Jun; 587(1-3):302-8. PubMed ID: 18420187
[TBL] [Abstract][Full Text] [Related]
25. Hepatoprotective effects of syringin on fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice.
Gong X; Zhang L; Jiang R; Wang CD; Yin XR; Wan JY
J Appl Toxicol; 2014 Mar; 34(3):265-71. PubMed ID: 23620140
[TBL] [Abstract][Full Text] [Related]
26. Secoisolariciresinol and isotaxiresinol inhibit tumor necrosis factor-alpha-dependent hepatic apoptosis in mice.
Banskota AH; Nguyen NT; Tezuka Y; Le Tran Q; Nobukawa T; Kurashige Y; Sasahara M; Kadota S
Life Sci; 2004 Apr; 74(22):2781-92. PubMed ID: 15043992
[TBL] [Abstract][Full Text] [Related]
27. Protective effects of Mg-CUD against D-galactosamine-induced hepatotoxicity in rats.
Choi JH; Kang JW; Kim DW; Sung YK; Lee SM
Eur J Pharmacol; 2011 Apr; 657(1-3):138-43. PubMed ID: 21284943
[TBL] [Abstract][Full Text] [Related]
28. The neuropeptide calcitonin gene-related peptide (CGRP) prevents inflammatory liver injury in mice.
Kroeger I; Erhardt A; Abt D; Fischer M; Biburger M; Rau T; Neuhuber WL; Tiegs G
J Hepatol; 2009 Aug; 51(2):342-53. PubMed ID: 19464067
[TBL] [Abstract][Full Text] [Related]
29. Anti-tumor necrosis factor α treatment promotes apoptosis and prevents liver regeneration in a transgenic mouse model of chronic hepatitis C.
Brenndörfer ED; Weiland M; Frelin L; Derk E; Ahlén G; Jiao J; Bode JG; Sällberg M
Hepatology; 2010 Nov; 52(5):1553-63. PubMed ID: 20886569
[TBL] [Abstract][Full Text] [Related]
30. Protective effect of linalool against lipopolysaccharide/D-galactosamine-induced liver injury in mice.
Li J; Zhang X; Huang H
Int Immunopharmacol; 2014 Dec; 23(2):523-9. PubMed ID: 25311666
[TBL] [Abstract][Full Text] [Related]
31. The protective effects of ursodeoxycholic acid on isoniazid plus rifampicin induced liver injury in mice.
Chen X; Xu J; Zhang C; Yu T; Wang H; Zhao M; Duan ZH; Zhang Y; Xu JM; Xu DX
Eur J Pharmacol; 2011 May; 659(1):53-60. PubMed ID: 21419764
[TBL] [Abstract][Full Text] [Related]
32. Ursodeoxycholic acid induces apoptosis of hepatocellular carcinoma cells in vitro.
Zhu L; Shan LJ; Liu YJ; Chen D; Xiao XG; Li Y
J Dig Dis; 2014 Dec; 15(12):684-93. PubMed ID: 25214410
[TBL] [Abstract][Full Text] [Related]
33. Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.
Munoz-Garrido P; Marin JJ; Perugorria MJ; Urribarri AD; Erice O; Sáez E; Úriz M; Sarvide S; Portu A; Concepcion AR; Romero MR; Monte MJ; Santos-Laso Á; Hijona E; Jimenez-Agüero R; Marzioni M; Beuers U; Masyuk TV; LaRusso NF; Prieto J; Bujanda L; Drenth JP; Banales JM
J Hepatol; 2015 Oct; 63(4):952-61. PubMed ID: 26044126
[TBL] [Abstract][Full Text] [Related]
34. N-acetylcysteine attenuates lipopolysaccharide-induced apoptotic liver damage in D-galactosamine-sensitized mice.
Wang H; Xu DX; Lu JW; Zhao L; Zhang C; Wei W
Acta Pharmacol Sin; 2007 Nov; 28(11):1803-9. PubMed ID: 17959032
[TBL] [Abstract][Full Text] [Related]
35. Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells.
Arenas F; Hervias I; Uriz M; Joplin R; Prieto J; Medina JF
J Clin Invest; 2008 Feb; 118(2):695-709. PubMed ID: 18188457
[TBL] [Abstract][Full Text] [Related]
36. Neurokinin-1 receptor antagonists CP-96,345 and L-733,060 protect mice from cytokine-mediated liver injury.
Bang R; Sass G; Kiemer AK; Vollmar AM; Neuhuber WL; Tiegs G
J Pharmacol Exp Ther; 2003 Apr; 305(1):31-9. PubMed ID: 12649350
[TBL] [Abstract][Full Text] [Related]
37. The secondary bile acids, ursodeoxycholic acid and lithocholic acid, protect against intestinal inflammation by inhibition of epithelial apoptosis.
Lajczak-McGinley NK; Porru E; Fallon CM; Smyth J; Curley C; McCarron PA; Tambuwala MM; Roda A; Keely SJ
Physiol Rep; 2020 Jun; 8(12):e14456. PubMed ID: 32562381
[TBL] [Abstract][Full Text] [Related]
38. Hepatoprotective effect of cryptotanshinone from Salvia miltiorrhiza in D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
Jin Q; Jiang S; Wu YL; Bai T; Yang Y; Jin X; Lian LH; Nan JX
Phytomedicine; 2014 Jan; 21(2):141-7. PubMed ID: 24011530
[TBL] [Abstract][Full Text] [Related]
39. Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma.
Lim SC; Choi JE; Kang HS; Han SI
Int J Cancer; 2010 Apr; 126(7):1582-95. PubMed ID: 19728331
[TBL] [Abstract][Full Text] [Related]
40. N-3 polyunsaturated fatty acid attenuates cholesterol gallstones by suppressing mucin production with a high cholesterol diet in mice.
Kim JK; Cho SM; Kang SH; Kim E; Yi H; Yun ES; Lee DG; Cho HJ; Paik YH; Choi YK; Haam SJ; Shin HC; Lee DK
J Gastroenterol Hepatol; 2012 Nov; 27(11):1745-51. PubMed ID: 22849613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
